Want to join the conversation?
Barclays analyst Matthew Taylor questions $ABT on the contribution of new products in Medical Devices segment. CEO Miles White says that the Vascular business is doing better with MitraClip being a big contributor. On the core stent business, there is pricing pressure due to stiff competition, but that business is gaining share and doing well.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.